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INTRODUCTION
Nontuberculous, or atypical mycobacteria (NTM) are known to cause
infectious keratitis, most of them caused by two species: M. fortuitum and M.
chelonae(1-2). Commonly, it occurs after either accidental or surgical trauma(3).
In 1965, Turner and Stinson(1) described the first case of NTM keratitis
in a corneal ulcer that developed 4 months after removal of a superficial
corneal body; M. fortuitum was identified as the etiological agent. More
recently, mycobacteria species were reported to cause infectious keratitis
after LASIK, photorefractive keratectomy, and radial keratectomy(4-5).
The purpose of this study is to describe a case of deep stromal myco-
bacterial keratitis in a 41-year-old patient that was considered cured after 6
months of clinical treatment and in reality, had viable microorganisms.
CASE REPORT
A 41-year-old male presented with blurred vision, hyperemia and pain in
Deep stromal mycobacterial keratitis: viable bacteria after
six months of treatment: case report and literature review
To report the presence of viable mycobacteria in a patient with keratitis
treated for 6 months. Species identification was performed using the PRA
method (polymerase chain reaction followed by restriction endonuclease
analysis). Clonality was evaluated with RAPD (randomly amplified poly-
morphic DNA) and ERIC-PCR (enterobacterial repetitive intergenic con-
sensus – polymerase chain reaction) methods. The patient reported trauma
due to a metallic foreign body 3 weeks prior to presentation. Initial corneal
scraping cultures revealed Mycobacterium abscessus. After 6 months of
topical and systemic treatment the patient presented with no active
inflammation and was considered clinically cured. An optic penetrating
keratoplasty was performed. Culture of the excised cornea revealed Myco-
bacterium abscessus. Both isolates had the same clonal origin. The most
interesting finding of this case report was the positive culture of the excised
cornea after 6 months of intensive specific topical therapy. To our know-
ledge, this is the first report in the literature showing this possibility in the
treatment of Mycobacterial keratitis. Thus, Mycobacterium abscessus
may present viable bacteria after long-term treatment and should be
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the right eye. He reported a trauma due to a metallic foreign
body in the affected eye 3 weeks before. Biomicroscopy sho-
wed conjunctival hyperemia and deep stromal infiltrates with
overlying epithelial defect (Figure 1). Left eye examination
was unremarkable. Best corrected visual acuity (BCVA) was
hand motion (OD) and 20/20 (OS). Corneal scrapings were
obtained and cultures revealed Mycobacterium abscessus,
identified by polymerase chain reaction followed by restric-
tion endonuclease analysis. Drug susceptibility was analyzed
through the Etest test. The minimal inhibitory concentrations
demonstrated susceptibility to: amikacin (12.0 µg/ml), clarith-
romycin (0.064 µg/ml), and cefoxitin (16 µg/ml); and resistance
to: ciprofloxacin (> 32µg/ml), imipenem (> 256µg/ml), tobra-
mycin (12 µg/ml), and doxycycline (> 32 µg/ml).
A superficial keratectomy was performed and the patient
was treated with topical 1% clarithromycin, 1.5% amikacin,
0.3% ofloxacin, and oral clarithromycin (500 mg 12/12h). Topi-
cal drops were administered every hour initially and then
tapered to every two hours and then maintained at a dosage of
every three hours for one month. After the first month the
drugs were instilled four times daily. Oral prednisone was
used to control initial inflammation (40 mg a day) and was
subsequently tapered (Figure 2).
After 6 months of treatment, the patient was considered
clinically cured (healed) and a penetrating keratoplasty (PK)
with optical purposes was performed. Surprisingly, culture of
the excised cornea revealed viable Mycobacterium abscessus.
Analysis of clonality with randomly amplified polymorphic
DNA(6) and ERIC-PCR (enterobacterial repetitive intergenic
consensus – polymerase chain reaction)(7) methods demons-
trated that isolates had the same clonal origin (Figure 3).
Topical prednisolone and clarithromycin were maintained
for 2 months. Ten months after the PK, BCVA was 20/40 with
no signs of infection recrudescence.
DISCUSSION
NTM are opportunistic pathogens requiring some distur-
bance in the normal ocular environment to produce infection.
NTM can cause infectious crystalline keratopathy(1), and cor-
neal infection is usually characterized by indolent course (re-
latively low virulence and slow rate of growth), and resistance
to medical treatment(2-3).
Patients’ complaints are usually of moderate pain, photo-
phobia and blurring vision. Clinical signs, which often deve-
lop within 2 to 8 weeks after inoculation reveal a paucity of
inflammation and the formation of a sharply demarcated gray-
white branching, round or needle-like opacities in the corneal
stroma. This crystalline keratopathic changes are due to colo-
nization of the organisms along the lamellar planes in the
stroma. Ring infiltrates are common and may cause confusion
with herpetic, fungal or Acanthamoeba keratitits. Intact over-
lying epithelium is sometimes observed and pain is variable,
but is certainly never as excruciating as in Acanthamoeba
keratitits(4). The degree of anterior chamber inflammation ap-
pears to parallel the gravity of the events in the cornea, and is
probably a reactive rather than an infectious phenomenon(4).
NTM can be isolated from a variety of environmental sites,
including, water, soil, animals, and food, which are easily
contaminated(4). Most species can survive nutritional depriva-
tion, extreme temperature (>45º C), and are resistant to the
action of formaldehyde, glutaraldehyde, and other commonly
used disinfectants. Positive nontuberculous mycobacterial
cultures on Lowenstein-Jensen agar medium constituted a
definitive diagnosis(3-4). Since these organisms are gram-posi-
tive and are infrequently isolated, they have at times, been
mistakenly identified in smears as diptheroid or nocardial(3)
species. Restriction endonuclease analysis can be helpful in
these cases, providing an accurate diagnosis(8).
The majority of cases, have been associated with a pre-
vious history of either a foreign body trauma(3) (metal or vege-
table material) or surgical trauma (radial keratotomy, penetra-
ting keratoplasty, suture removal, surgical posterior capsulo-
tomy, and even simply wear of contact lens)(2). Unsatisfactory
medical therapy, can be associated with a delayed diagnosis,
slow response to therapy, inadequate drug penetration, resis-
tance to most conventional antibiotics and the emergence of a
resistant strain, especially when using monotherapy (3,5).
Figure 1 - Clinical photograph of the right eye. Biomicroscopy demons-
trating deep stromal infiltrates and hypopyon
Figure 2 - One month after the PK for visual rehabilitation
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Keratitis caused by mycobacteria has proved to be difficult
to treat. Aggressive long-term therapy with a combination of
topical fortified antibiotics and sometimes oral medications is
usually necessary to control the infection(3-4), and although
corticosteroid therapy results in transient improvement of the
inflammation and scarring, it might contribute to failure of
medical treatment and the chronicity of the disease(4). In our
case, we achieved good clinical results with the aforementioned
medications and after 6 months our patient was considered
clinically cured without signs of active infection/inflammation.
The most interesting finding of this report was the positive
culture of the excised cornea after 6 months of intensive
specific therapy which demonstrates that clinical cure may not
correlate with sterility of scar tissue. To our knowledge, this is
the first report in the literature showing this possibility in the
treatment of mycobacterial keratitis.
Thus, Mycobacterium abscessus in deep stromal keratitis
may be viable after long-term treatment. Finally, patients
should be followed carefully for a long period after tapering
Figure 3 – Agarose gel electrophoresis of amplified DNA from clinical
isolates of Mycobacterium abscessus, obtained by ERIC-PCR or
RAPD-PCR methods. Lanes. A: DNA standards; B: RAPD-Control 1; C:
RAPD-Control 2; D: RAPD - Patient initial isolate; E: RAPD - Patient iso-
late after 6 months of treatment; F: ERIC-Control 1; G: ERIC-Control 2;
H: ERIC - Patient initial isolate; I) RAPD – Patient isolate after 6 months
of treatment; J: DNA standards. Control 1 and 2 are clinical isolates
known to present the same clonal origin. Arrows indicate the identical
patterns of the two isolates from the patient in both methods
the medication in order to clinical cure to be proved and
patients undergoing PK should have a laboratory work-up of
the excised cornea.
RESUMO
O objetivo do caso é descrever a presença de micobactérias
viáveis em pacientes com ceratite, 6 meses após tratamento
intensivo. A identificação de espécies, foi efetuada usando
método PRA (polymerase chain reaction seguida pela res-
triction endonuclease analysis). Clonalidade foi avaliada pe-
los métodos RAPD (randomly amplified polymorphic DNA) e
ERIC-PCR (enterobacterial repetitive intergenic consensus –
polymerase chain reaction). Paciente refere trauma com corpo
estranho metálico há 3 semanas. A cultura da córnea revelou
Mycobacterium abscessus. Após 6 meses de tratamento tópi-
co e sistêmico, paciente apresentava-se sem inflamação, sen-
do considerado clinicamente curado. Realizou-se então, uma
ceratoplastia penetrante com intuitos ópticos. A cultura da
córnea transplantada revelou micobactérias de mesma origem
clonal. O achado mais interessante neste relato, foi a positivi-
dade da cultura da córnea transplantada após 6 meses de
intenso tratamento específico. Ao nosso conhecimento, esse
é o primeiro caso relatado na literatura mostrando essa possi-
bilidade em tratamento de ceratites por micobactérias. Assim,
os pacientes com ceratite por Mycobacterium abscessus po-
dem apresentar bactérias viáveis após longo tempo de trata-
mento específico e precisam ser seguidos cuidadosamente por
um longo período de tempo.
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